Literature DB >> 26221201

Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.

Shijie Zhang1, Hexing Wu1, Xiangwei Wu1, Webo Lian1, Yanchao Wang1, Xiaozhao Zhang1, Xinyu Peng1.   

Abstract

Genetic variants of PNPLA3 have been implicated in hepatocellular carcinoma (HCC) susceptibility; however, published findings have been both conflicting and inconclusive. To obtain a more precise estimate of the association of the PNPLA3 rs738409 (C > G) polymorphism with the overall risk of HCC and in patients with cirrhosis, we performed a meta-analysis of nine eligible studies identified through an online search of Ovid, PubMed, EBSCO, the Cochrane Library, the Web of Science, the China National Knowledge Infrastructure, Wanfang, and Chinese Biomedicine databases. The studies comprised 1175 patients with HCC, 876 with cirrhosis, and 3026 healthy controls. Pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated to assess associations, using fixed-effects models. Etiology subgroup and sensitivity analyses were also performed. Our results showed that rs738409 was associated with overall HCC risk and in patients with cirrhosis in the genetic contrast modes: G vs. C, GG + CG vs. CC, GG vs. CG + GG, and GG vs. CC. Stratification by etiology did not reveal any significant association between this polymorphism and hepatitis C virus (HCV)-related HCC in patients with HCV-related cirrhosis (P > 0.05). However, healthy individuals harboring two copies of the rs738409 G variant had a higher risk of HCC (GG vs. CC: OR = 4.40, 95% CI: 3.28-5.91) than those carrying a single G allele (CG vs. CC: OR = 1.62, 95% CI: 1.34-1.59); these significant association were also present in each subgroup. Furthermore, the association was more pronounced in alcohol vs. HCV-related HCC. The present meta-analysis suggests that the PNPLA3 rs738409 G allele is a risk factor for HCC except in patients with HCV-related cirrhosis, and that two copies of the rs738409 G variant conferred a higher risk for HCC in controls, especially for alcohol-related HCC. Further studies with a larger sample size are needed to ascertain the association in different ethnicities.

Entities:  

Keywords:  PNPLA3; adiponutrin; genetic polymorphism; hepatocellular carcinoma; meta-analysis

Year:  2015        PMID: 26221201      PMCID: PMC4509146     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  47 in total

Review 1.  Hepatocellular carcinoma: present status and future prospects.

Authors:  Josep M Llovet; Michel Beaugrand
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

4.  Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt.

Authors:  Faten Zahran Mohamed; Yousry Mostafa Hussein; Ibrahim Mohey El-Deen; Marwa Sayed Sabea
Journal:  Mol Biol Rep       Date:  2014-01-08       Impact factor: 2.316

5.  PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.

Authors:  Kilian Friedrich; Andreas Wannhoff; Stefan Kattner; Maik Brune; Johannes Roksund Hov; Karl Heinz Weiss; Christoph Antoni; Matthias Dollinger; Christoph Neumann-Haefelin; Thomas Seufferlein; Peter Schemmer; Peter Schirmacher; Wolfgang Stremmel; Daniel Nils Gotthardt
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

6.  N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.

Authors:  Md Bayejid Hosen; Jahidul Islam; Md Abdus Salam; Md Fakhrul Islam; M Zakir Hossain Hawlader; Yearul Kabir
Journal:  Asia Pac J Clin Oncol       Date:  2014-11-06       Impact factor: 2.601

Review 7.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 8.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

9.  XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese.

Authors:  Chibo Liu; Haibao Wang
Journal:  Tumour Biol       Date:  2013-04-05

10.  Correlation between patatin-like phospholipase domain-containing protein 3 gene polymorphisms and liver cirrhosis in a chinese han population with chronic hepatitis B.

Authors:  Jin Tong; Jinjun Guo; Jun Hu; Sihui Hou; Yu Zhang; Qingling Li
Journal:  Hepat Mon       Date:  2014-08-17       Impact factor: 0.660

View more
  1 in total

Review 1.  PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease.

Authors:  Xiaocheng Charlie Dong
Journal:  Front Med (Lausanne)       Date:  2019-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.